Cargando…
The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants
BACKGROUND: Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091911/ https://www.ncbi.nlm.nih.gov/pubmed/27806112 http://dx.doi.org/10.1371/journal.pone.0165727 |
_version_ | 1782464657157521408 |
---|---|
author | Czech-Kowalska, Justyna Czekuc-Kryskiewicz, Edyta Pludowski, Pawel Zaniuk, Katarzyna Jaworski, Maciej Łuba, Anna Grzybowska, Karolina Piłat, Krystyna Dobrzanska, Anna |
author_facet | Czech-Kowalska, Justyna Czekuc-Kryskiewicz, Edyta Pludowski, Pawel Zaniuk, Katarzyna Jaworski, Maciej Łuba, Anna Grzybowska, Karolina Piłat, Krystyna Dobrzanska, Anna |
author_sort | Czech-Kowalska, Justyna |
collection | PubMed |
description | BACKGROUND: Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but is not widely available. AIM: To investigate the clinical and biochemical parameters, including bone metabolism markers as potential predictors of BMC, in preterm infants up to 3 months corrected age (CA). MATERIALS AND METHODS: Ca-P homeostasis, iPTH, 25-hydroxyvitamin D, osteocalcin, N-terminal propeptide, cross-linked C-telopeptide and amino-terminal pro C-type natriuretic peptide and the DXA scans were prospectively performed in 184 preterm infants (≤ 34 weeks’ gestation) between term age and 3 mo CA. Lower bone mass was defined as BMC below or equal to respective median value for the whole study group, rounded to the nearest whole number. RESULTS: The appropriate quality DXA scans were available for 160 infants (87%) examined at term and for 130 (71%) tested at 3 mo CA. Higher iPTH level was the only independent predictor of lower BMC at term, whereas lower BMC at 3 mo CA was associated both with lower urinary phosphate excretion and higher serum osteocalcin level. ROC analysis showed that iPTH >43.6 pg/mL provided 40% sensitivity and 88% specificity in identification of preterm infants with lower BMC at term. In turn, urinary phosphate excretion (TRP>97% or UP/Cr ≤0.74 mg/mg) and serum osteocalcin >172 ng/mL provided 40% sensitivity and 93% specificity in identification of infants with decreased BMC at 3 mo CA. CONCLUSION: Serum iPTH might to be a simple predictor of reduced BMC in preterm infants at term age, but urinary phosphate excretion and serum osteocalcin might predict reduced BMC at 3 mo CA. These results represent a promising diagnostic tool based on simple, widely available biochemical measurements for bone mass assessment in preterm infants. |
format | Online Article Text |
id | pubmed-5091911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-50919112016-11-15 The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants Czech-Kowalska, Justyna Czekuc-Kryskiewicz, Edyta Pludowski, Pawel Zaniuk, Katarzyna Jaworski, Maciej Łuba, Anna Grzybowska, Karolina Piłat, Krystyna Dobrzanska, Anna PLoS One Research Article BACKGROUND: Metabolic bone disease of prematurity still occurs in preterm infants, although a significant improvement in neonatal care has been observed in recent decades. Dual-energy X-ray absorptiometry (DXA) is the precise technique for assessing bone mineral content (BMC) in preterm infants, but is not widely available. AIM: To investigate the clinical and biochemical parameters, including bone metabolism markers as potential predictors of BMC, in preterm infants up to 3 months corrected age (CA). MATERIALS AND METHODS: Ca-P homeostasis, iPTH, 25-hydroxyvitamin D, osteocalcin, N-terminal propeptide, cross-linked C-telopeptide and amino-terminal pro C-type natriuretic peptide and the DXA scans were prospectively performed in 184 preterm infants (≤ 34 weeks’ gestation) between term age and 3 mo CA. Lower bone mass was defined as BMC below or equal to respective median value for the whole study group, rounded to the nearest whole number. RESULTS: The appropriate quality DXA scans were available for 160 infants (87%) examined at term and for 130 (71%) tested at 3 mo CA. Higher iPTH level was the only independent predictor of lower BMC at term, whereas lower BMC at 3 mo CA was associated both with lower urinary phosphate excretion and higher serum osteocalcin level. ROC analysis showed that iPTH >43.6 pg/mL provided 40% sensitivity and 88% specificity in identification of preterm infants with lower BMC at term. In turn, urinary phosphate excretion (TRP>97% or UP/Cr ≤0.74 mg/mg) and serum osteocalcin >172 ng/mL provided 40% sensitivity and 93% specificity in identification of infants with decreased BMC at 3 mo CA. CONCLUSION: Serum iPTH might to be a simple predictor of reduced BMC in preterm infants at term age, but urinary phosphate excretion and serum osteocalcin might predict reduced BMC at 3 mo CA. These results represent a promising diagnostic tool based on simple, widely available biochemical measurements for bone mass assessment in preterm infants. Public Library of Science 2016-11-02 /pmc/articles/PMC5091911/ /pubmed/27806112 http://dx.doi.org/10.1371/journal.pone.0165727 Text en © 2016 Czech-Kowalska et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Czech-Kowalska, Justyna Czekuc-Kryskiewicz, Edyta Pludowski, Pawel Zaniuk, Katarzyna Jaworski, Maciej Łuba, Anna Grzybowska, Karolina Piłat, Krystyna Dobrzanska, Anna The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants |
title | The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants |
title_full | The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants |
title_fullStr | The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants |
title_full_unstemmed | The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants |
title_short | The Clinical and Biochemical Predictors of Bone Mass in Preterm Infants |
title_sort | clinical and biochemical predictors of bone mass in preterm infants |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091911/ https://www.ncbi.nlm.nih.gov/pubmed/27806112 http://dx.doi.org/10.1371/journal.pone.0165727 |
work_keys_str_mv | AT czechkowalskajustyna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT czekuckryskiewiczedyta theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT pludowskipawel theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT zaniukkatarzyna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT jaworskimaciej theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT łubaanna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT grzybowskakarolina theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT piłatkrystyna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT dobrzanskaanna theclinicalandbiochemicalpredictorsofbonemassinpreterminfants AT czechkowalskajustyna clinicalandbiochemicalpredictorsofbonemassinpreterminfants AT czekuckryskiewiczedyta clinicalandbiochemicalpredictorsofbonemassinpreterminfants AT pludowskipawel clinicalandbiochemicalpredictorsofbonemassinpreterminfants AT zaniukkatarzyna clinicalandbiochemicalpredictorsofbonemassinpreterminfants AT jaworskimaciej clinicalandbiochemicalpredictorsofbonemassinpreterminfants AT łubaanna clinicalandbiochemicalpredictorsofbonemassinpreterminfants AT grzybowskakarolina clinicalandbiochemicalpredictorsofbonemassinpreterminfants AT piłatkrystyna clinicalandbiochemicalpredictorsofbonemassinpreterminfants AT dobrzanskaanna clinicalandbiochemicalpredictorsofbonemassinpreterminfants |